Age-related alterations in retinal neurovascular and inflammatory transcripts

Molecular Vision

Volumn 17, Issue , 2011, Pages 1261-1274

  van Hirk, Collen A ^a   VanGuilder, Heather D ^a   Young, Megan ^a   Farley, Julie A ^b   Sonntag, William E ^b   Freeman, Willard M ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHITINASE 3 LIKE 1 GENE; COMPLEMENT COMPONENT 1 S SUBCOMPONENT GENE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ENDOTHELIN 2 GENE; GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GFAP GENE; GLUCOSE BLOOD LEVEL; GLUTAMATE RECEPTOR IONOTROPIC NMDA 2A GENE; GUANYLATE NUCLEOTIDE BINDING PROTEIN 2 GENE; INTERCELLULAR ADHESION MOLECULE 1 GENE; JANUS KINASE 3 GENE; LIPOPOLYSACCHARIDE INDUCED TNF FACTOR GENE; MALE; MICROANGIOPATHY; NONHUMAN; PIGMENT EPITHELIUM DERIVED GROWTH FACTOR GENE; POLYCOMB GROUP RING FINGER 1 GENE; PRIORITY JOURNAL; RAT; RETINITIS; SERPING1 GENE; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 GENE; TRANSCRIPTION REGULATION; TUMOR NECROSIS FACTOR RECEPTOR SUBFAMILY MEMBER 12A GENE; UPREGULATION;

AGING; ANIMALS; BLOOD GLUCOSE; HYBRIDIZATION, GENETIC; INFLAMMATION; MALE; MICROCIRCULATION; NEURONS; RATS; RATS, INBRED BN; RATS, INBRED F344; RETINA; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79957449275     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. National Eye Institute. Prevalence of blindness and low vision among adults aged 40 years and older in the United States. Bethesda, MD National Eye Institute 2004; Available at http://www.nei.nih.gov/eyedata/pbd_tables.asp:
2. Trick LR. Age-related alterations in retinal function. Doc Ophthalmol 1987; 65:35-43.PMID: 3665700
3. Bonnel S, Mohand-Said S, Sahel JA. The aging of the retina. Exp Gerontol 2003; 38:825-31.[PMID: 12915204]
4. Jackson GR, Owsley C, Cordle EP, Finley CD. Aging and scotopic sensitivity. Vision Res 1998; 38:3655-62.[PMID:9893796]
5. Owsley C, Sekuler R, Siemsen D. Contrast sensitivity throughout adulthood. Vision Res 1983; 23:689-99.[PMID: 6613011]
6. Sloane ME, Owsley C, Jackson CA. Aging and luminance-adaptation effects on spatial contrast sensitivity. J Opt Soc Am A 1988; 5:2181-90.[PMID: 3230488]
7. Sloane ME, Owsley C, Alvarez SL. Aging, senile miosis and spatial contrast sensitivity at low luminance. Vision Res 1988;28:1235-46.[PMID: 3253994]
8. Jackson GR, Owsley C, McGwin G Jr. Aging and dark adaptation. Vision Res 1999; 39:3975-82.[PMID: 10748929]
9. Birch DG, Anderson JL. Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol 1992; 110:1571-6.[PMID: 1444914]
10. Jackson GR, Ortega J, Girkin C, Rosenstiel CE, Owsley C. Aging-related changes in the multifocal electroretinogram. J Opt Soc Am A Opt Image Sci Vis 2002; 19:185-9.[PMID: 11778722]
11. Kurtenbach A, Weiss M. Effect of aging on multifocal oscillatory potentials. J Opt Soc Am A Opt Image Sci Vis 2002; 19:190-6.[PMID: 11778724]
12. Weleber RG. The effect of age on human cone and rod ganzfeld electroretinograms. Invest Ophthalmol Vis Sci 1981;20:392-9.[PMID: 7203883]
13. Gerth C, Garcia SM, Ma L, Keltner JL, Werner JS. Multifocal electroretinogram: age-related changes for different luminance levels. Graefes Arch Clin Exp Ophthalmol 2002;240:202-8.[PMID: 11935277]
14. Ehrlich R, Kheradiya NS, Winston DM, Moore DB, Wirostko B, Harris A. Age-related ocular vascular changes. Graefes Arch Clin Exp Ophthalmol 2009; 247:583-91.[PMID: 19084984]
15. Kneser M, Kohlmann T, Pokorny J, Tost F. Age related decline of microvascular regulation measured in healthy individuals by retinal dynamic vessel analysis. Med Sci Monit 2009;15:CR436-41.[PMID: 19644422]
16. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Rickman CB, Bok D, Hageman GS, Johnson LV. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 2010; 29:95-112.[PMID: 19961953]
17. Boulton M, Roanowska M, Wess T. Ageing of the retinal pigment epithelium: implications for transplantation. Graefes Arch Clin Exp Ophthalmol 2004; 242:76-84.[PMID:14663593]
18. Ehrlich R, Harris A, Kheradiya NS, Winston DM, Ciulla TA, Wirostko B. Age-related macular degeneration and the aging eye. Clin Interv Aging 2008; 3:473-82.[PMID: 18982917]
19. Johansen JS, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK, Bruunsgaard H. High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Clin Exp Immunol 2008; 151:260-6.[PMID:18070151]
20. Chan-Ling T, Hughes S, Baxter L, Rosinova E, McGregor I, Morcos Y, van NP, and Hu P. Inflammation and breakdown of the blood-retinal barrier during "physiological aging" in the rat retina: a model for CNS aging. Microcirculation 2007; 14:63-76.[PMID: 17365662]
21. Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, Ufret RL, Salomon RG, Perez VL. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008; 14:194-8.[PMID: 18223656]
22. Roy S, Tonkiss J, Roy S. Aging increases retinal vascular lesions characteristic of early diabetic retinopathy. Biogerontology 2010; 11:447-55.[PMID: 20119717]
23. Parapuram SK, Cojocaru RI, Chang JR, Khanna R, Brooks M, Othman M, Zareparsi S, Khan NW, Gotoh N, Cogliati T, Swaroop A. Distinct signature of altered homeostasis in aging rod photoreceptors: implications for retinal diseases. PLoS ONE 2010; 5:e13885.[PMID: 21079736]
24. Artola A, Kamal A, Ramakers GM, Gardoni F, Di LM, Biessels GJ, Cattabeni F, Gispen WH. Synaptic plasticity in the diabetic brain: advanced aging? Prog Brain Res 2002;138:305-14.[PMID: 12432776]
25. Artola A, Kamal A, Ramakers GM, Biessels GJ, Gispen WH. Diabetes mellitus concomitantly facilitates the induction of long-term depression and inhibits that of long-term potentiation in hippocampus. Eur J Neurosci 2005;22:169-78.[PMID: 16029206]
26. Artola A. Diabetes-, stress- and ageing-related changes in synaptic plasticity in hippocampus and neocortex-the same metaplastic process? Eur J Pharmacol 2008; 585:153-62.[PMID: 18395200]
27. Trougakos IP, Poulakou M, Stathatos M, Chalikia A, Melidonis A, Gonos ES. Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp Gerontol 2002; 37:1175-87.[PMID: 12470829]
28. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14:S1-85.[PMID: 9450510]
29. Nooyens AC, Baan CA, Spijkerman AM, Verschuren WM. Type 2 diabetes mellitus and cognitive decline in middle-aged men and women-The Doetinchem Cohort Study. Diabetes Care 2010; 33:1964-9.[PMID: 20519662]
30. Bourdel-Marchasson I, Lapre E, Laksir H, Puget E. Insulin resistance, diabetes and cognitive function: consequences for preventative strategies. Diabetes Metab 2010; 36:173-81.[PMID: 20472485]
31. Tomar RH, Lee S, Wu SY, Klein R, Klein BE, Moss SE, Fryback DG, Tollios JL, Sainfort F. Disease progression and cost of insulin dependent diabetes mellitus: development and application of a simulation model. J Soc Health Syst 1998; 5:24-37.[PMID: 9785295]
32. Klein R, Marino EK, Kuller LH, Polak JF, Tracy RP, Gottdiener JS, Burke GL, Hubbard LD, Boineau R. The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol 2002; 86:84-90.[PMID: 11801510]
33. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105:1801-15.[PMID: 9787347]
34. Aiello LM. Preservin g human vision: eliminating blindness from diabetes mellitus. J Am Optom Assoc 1998; 69:690-2.[PMID: 9844319]
35. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL III, Knatterud GL. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 1998;39:233-52.[PMID:9477980]
36. Frost-Larsen K, Larsen HW, Simonsen SE. Value of electroretinography and dark adaptation as prognostic tools in diabetic retinopathy. Dev Ophthalmol 1981; 2:222-34.[PMID: 7262405]
37. Hyvärinen L, Laurinen P, Rovamo J. Contrast sensitivity in evaluation of visual impairment due to diabetes. Acta Ophthalmol (Copenh) 1983; 61:94-101.[PMID: 6858649]
38. Sokol S, Moskowitz A, Skarf B, Evans R, Molitch M, Senior B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol 1985; 103:51-4.[PMID: 3977675]
39. Di Leo MA, Caputo S, Falsini B, Porciatti V, Greco AV, Ghirlanda G. Presence and further development of retinal dysfunction after 3-year follow up in IDDM patients without angiographically documented vasculopathy. Diabetologia 1994; 37:911-6.[PMID: 7806021]
40. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006;26:275-8.[PMID:16508426]
41. Di Leo MA, Caputo S, Falsini B, Porciatti V, Minnella A, Greco AV, Ghirlanda G. Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care 1992; 15:620-5.[PMID: 1516480]
42. Dosso AA, Bonvin ER, Morel Y, Golay A, Assal JP, Leuenberger PM. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol 1996; 234:300-5.[PMID: 8740250]
43. Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci 2000; 41:3561-8.[PMID: 1006253]
44. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, Lanoue KF, Norbury CC, Quinn PG, Sandirasegarane L, Simpson IA. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006; 55:2401-11.[PMID: 16936187]
45. Brucklacher RM, Patel KM, VanGuilder HD, Bixler GV, Barber AJ, Antonetti DA, Lin CM, Lanoue KF, Gardner TW, Bronson SK, Freeman WM. Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics 2008; 1:26.
46. Freeman WM, Bixler GV, Brucklacher RM, Lin CM, Patel KM, Vanguilder HD, Lanoue KF, Kimball SR, Barber AJ, Antonetti DA, Gardner TW, Bronson SK. A multistep validation process of biomarkers for preclinical drug development. Pharmacogenomics J 2010; 10:385-95.[PMID: 19997081]
47. VanGuilder HD, Brucklacher RM, Patel K, Ellis RW, Freeman WM, Barber AJ. Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina. Eur J Neurosci 2008; 28:1-11.[PMID: 18662330]
48. Freeman WM, Bixler GV, Brucklacher RM, Walsh E, Kimball SR, Jefferson LS, Bronson SK. Transcriptomic comparison of the retina in two mouse models of diabetes. J Ocul Biol Dis Infor 2009; 2:202-13.[PMID: 20157355]
49. VanGuilder HD, Bixler GV, Kutzler L, Brucklacher RM, Bronson SK, Kimball SR, Freeman WM. Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy. PLoS ONE 2011;6:e16271.[PMID: 21249158]
50. Xu H, Chen M, Forrester JV. Para-inflammation in the aging retina. Prog Retin Eye Res 2009; 28:348-68.[PMID: 19560552]
51. VanGuilder HD, Yan H, Farley JA, Sonntag WE, Freeman WM. Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome. J Neurochem 2010; 113:1577-88.[PMID: 20374424]
52. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001; 25:402-8.[PMID: 11846609]
53. VanGuilder HD, Vrana KE, Freeman WM. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 2008; 44:619-26.[PMID: 18474036]
54. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B Stat Meth 1995; 57:289-300.
55. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neuro degeneration, and inflammation. Glycobiology 2005; 15:16R-28R.[PMID: 15764591]
56. Qiu C, Cotch MF, Sigurdsson S, Garcia M, Klein R, Jonasson F, Klein BE, Eiriksdottir G, Harris TB, van Buchem MA, Gudnason V, Launer LJ. Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study. Diabetes 2008; 57:1645-50.[PMID: 18332097]
57. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454:428-35.[PMID: 18650913]
58. Hagino N, Kobayashi S, Tsutsumi T, Horiuchi S, Nagai R, Setalo G, Dettrich E. Vascular change of hippocampal capillary is associated with vascular change of retinal capillary in aging. Brain Res Bull 2004; 62:537-47.[PMID: 15036569]
59. Qiu C, Cotch MF, Sigurdsson S, Klein R, Jonasson F, Klein BE, Garcia M, Jonsson PV, Harris TB, Eiriksdottir G, Kjartansson O, van Buchem MA, Gudnason V, Launer LJ. Microvascular lesions in the brain and retina: The age, gene/environment susceptibility-Reykjavik study. Ann Neurol 2009; 65:569-76.[PMID: 19475677]
60. Khalfaoui T, Lizard G, Beltaief O, Colin D, Ben HJ, Errais K, Ammous I, Zbiba W, Tounsi L, Zhioua R, Anane R, Ouertani-Meddeb A. Immunohistochemical analysis of cellular adhesion molecules (ICAM-1, VCAM-1) and VEGF in fibrovascular membranes of patients with proliferative diabetic retinopathy: preliminary study. Pathol Biol (Paris) 2009; 57:513-7.[PMID: 18834676]
61. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 2001; 158:147-52.[PMID: 11141487]
62. Chen M, Muckersie E, Forrester JV, Xu H. Immune activation in Retinal Aging: A Gene Expression Study. Invest Ophthalmol Vis Sci 2010; 51:5888-96.[PMID: 20538981]
63. Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 1999; 96:10836-41.[PMID: 10485912]
64. Lam HC, Lee JK, Lu CC, Chu CH, Chuang MJ, Wang MC. Role of endothelin in diabetic retinopathy. Curr Vasc Pharmacol 2003; 1:243-50.[PMID: 15320471]
65. Rattner A, Nathans J. The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia. J Neurosci 2005; 25:4540-9.[PMID: 15872101]
66. Chung HK, Choi SM, Ahn BO, Kwak HH, Kim JH, Kim WB. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy. Arzneimittelforschung 2005; 55:573-80.[PMID: 16294503]
67. Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 1998; 47:401-6.[PMID: 9519746]
68. Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P. Expression of acute-phase response proteins in retinal Muller cells in diabetes. Invest Ophthalmol Vis Sci 2005; 46:349-57.[PMID: 15623795]
69. Gong Y, Wang X, Liu J, Shi L, Yin B, Peng X, Qiang B, Yuan J. NSPc1, a mainly nuclear localized protein of novel PcG family members, has a transcription repression activity related to its PKC phosphorylation site at S183. FEBS Lett 2005; 579:115-21.[PMID: 15620699]
70. Wu X, Gong Y, Yue J, Qiang B, Yuan J, Peng X. Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing. Nucleic Acids Res 2008; 36:3590-9.[PMID: 18460542]
71. Arning L, Kraus PH, Valentin S, Saft C, Andrich J, Epplen JT. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics 2005; 6:25-8.[PMID: 15742215]
72. Chen M, Muckersie E, Robertson M, Forrester JV, Xu H. Up-regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. Exp Eye Res 2008; 87:543-50.[PMID: 18926817]
73. Khalyfa A, Chlon T, Qiang H, Agarwal N, Cooper NG. Microarray reveals complement components are regulated in the serum-deprived rat retinal ganglion cell line. Mol Vis 2007; 13:293-308.[PMID: 17356516]
74. Rathcke CN, Vestergaard H. YKL-40-an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 2009; 8:61.[PMID: 19930630]
75. Nielsen AR, Erikstrup C, Johansen JS, Fischer CP, Plomgaard P, Krogh-Madsen R, Taudorf S, Lindegaard B, Pedersen BK. Plasma YKL-40: a BMI-independent marker of type 2 diabetes. Diabetes 2008; 57:3078-82.[PMID: 18650368]
76. Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 2009; 32:323-8.[PMID: 18957531]
77. O'Shea JJ, Pesu M, Borie DC, Changelian PS. A new modality for immunosuppression: targeting the JAK/STAT pathway. Nat Rev Drug Discov 2004; 3:555-64.[PMID: 15232577]
78. Srinivasan S, Leeman SE, Amar S. Beneficial dysregulation of the time course of inflammatory mediators in lipopolysaccharide-induced tumor necrosis factor alpha factor-deficient mice. Clin Vaccine Immunol 2010; 17:699-704.[PMID: 20219876]
79. Ebihara N, Nakayama M, Tokura T, Iwatsu M, Ushio H, Murakami A. Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells. Curr Eye Res 2009; 34:836-44.[PMID: 19895311]
80. Ho DH, Vu H, Brown SA, Donohue PJ, Hanscom HN, Winkles JA. Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice. Cancer Res 2004; 64:8968-72.[PMID: 15604260]
81. Katakami N, Kaneto H, Yamasaki Y, Matsuhisa M. Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy. Diabetes Res Clin Pract 2008; 81:e4-7.[PMID: 18455830]
82. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285:245-8.[PMID: 10398599]
83. Sheikpranbabu S, Haribalaganesh R, Lee KJ, Gurunathan S. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability. Biochimie 2010; 92:1040-51.[PMID: 20470857]
84. Gao BB, Clermont A, Rook S, Fonda SJ, Srinivasan VJ, Wojtkowski M, Fujimoto JG, Avery RL, Arrigg PG, Bursell SE, Aiello LP, Feener EP. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med 2007; 13:181-8.[PMID: 17259996]
85. Paulus YM, Gariano RF. Diabetic retinopathy: a growing concern in an aging population. Geriatrics 2009; 64:16-20.[PMID: 19256582]